Skip to main content

ResMed| diluted shares

  • RMD · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$239.53+0.27%Close 13 Nov 2026 · Market value $33.91B

ResMed|'s diluted shares was 146M shares for fiscal year 2026 (the twelve months to 30 Jun 2026), down 0.9% from fiscal 2025.

In the first quarter of fiscal 2027 (the three months to 30 Sep 2026) it was 143M shares, down 2.4% from a year earlier.

From ResMed|'s annual and quarterly reports, compiled and checked by AapWire. Latest report filed 30 Oct 2026.

Fiscal 2026
146M
−0.9%
Q1 FY2027
143M
−2.4% on a year
Growth over 9 years
+0.3%
a year, FY 2017–FY 2026

Diluted shares by fiscal year

142MFY 2017144MFY 2018+1.1%144MFY 2019+0.3%146MFY 2020+0.8%146MFY 2021+0.5%147MFY 2022+0.4%147MFY 2023+0.3%148MFY 2024+0.1%147MFY 2025−0.1%146MFY 2026−0.9%

Change on the year before, under each year. From FY 2017 to FY 2026, ResMed|'s diluted shares went from 142M shares to 146M shares, a compound annual change of +0.3%; the highest was 148M shares in FY 2024.

ResMed| diluted shares, fiscal years
PeriodFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Diluted shares142M144M144M146M146M147M147M148M147M146M
Period end30 Jun 201730 Jun 201830 Jun 201930 Jun 202030 Jun 202130 Jun 202230 Jun 202330 Jun 202430 Jun 202530 Jun 2026

Diluted shares by quarter

The last eight fiscal quarters. Each is compared with the same quarter a year earlier on the company's page.

ResMed| diluted shares, fiscal quarters
PeriodQ2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Diluted shares147M147M147M147M146M146M145M143M
Period end31 Dec 202431 Mar 202530 Jun 202530 Sep 202531 Dec 202531 Mar 202630 Jun 202630 Sep 2026

How diluted shares is measured

Diluted shares is the weighted average number of shares outstanding in the period, counting the shares that options, warrants and convertible securities could add; it is the count earnings per share is divided by. Figures are read from the report the company filed and checked against accounting identities; one that does not pass is left blank rather than estimated. See data and methodology.

ResMed|'s other figures

Diluted shares of comparable companies

Everything on RMD, in the terminal.

Twenty years of history, operating KPIs and segments, guidance against results, valuation, insiders and holders, charts and alerts.